ROS1 OVEREXPRESSION BY IMMUNOHISTOCHEMISTRY IN NON-SMALL CELL LUNG CANCER: CLINICAL CHARACTERISTICS, NATURAL HISTORY AND POTENTIAL NEW THERAPEUTIC TARGET BASED ON TWO AUSTRALIAN CASES

MLA

Li, Bob T., et al. Ros1 Overexpression by Immunohistochemistry in Non-Small Cell Lung Cancer: Clinical Characteristics, Natural History and Potential New Therapeutic Target Based on Two Australian Cases. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4634ef777ad773a512a5f3146e88948b&authtype=sso&custid=ns315887. Accessed 23 Jan. 2025.

APA

Li, B. T., Anthony Gill, Dodds, T., Lee, A., Cooper, W. A., Clarke, S., & Pavlakis, N. (n.d.). Ros1 Overexpression by Immunohistochemistry in Non-Small Cell Lung Cancer: Clinical Characteristics, Natural History and Potential New Therapeutic Target Based on Two Australian Cases.

Chicago

Li, Bob T., Anthony Gill, Tristan Dodds, Adrian Lee, Wendy A. Cooper, Stephen Clarke, and Nick Pavlakis. 2025. “Ros1 Overexpression by Immunohistochemistry in Non-Small Cell Lung Cancer: Clinical Characteristics, Natural History and Potential New Therapeutic Target Based on Two Australian Cases.” Accessed January 23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4634ef777ad773a512a5f3146e88948b&authtype=sso&custid=ns315887.